IGF2BP1 and colorectal carcinoma: Overall, these results demonstrated that LOC101928222 synergizes with IGF2BP1 to stabilize HMGCS2 mRNA through an m6A-dependent pathway, leading to increased cholesterol synthesis, and, ultimately, the promotion of CRC development (Fig. 8E).